vs
Acadia Healthcare Company, Inc.（ACHC）与Rivian Automotive, Inc.（RIVN）财务数据对比。点击上方公司名可切换其他公司
Rivian Automotive, Inc.的季度营收约是Acadia Healthcare Company, Inc.的1.6倍（$1.3B vs $821.5M），Rivian Automotive, Inc.净利率更高（-63.1% vs -143.3%，领先80.3%），Acadia Healthcare Company, Inc.同比增速更快（6.1% vs -25.8%），Acadia Healthcare Company, Inc.自由现金流更多（$-179.5M vs $-1.1B），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（3.4% vs 3.3%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Rivian Automotive是2009年成立的美国电动汽车制造商及汽车科技企业，主打基于自研滑板平台打造的电动SUV、皮卡及EDV电动配送货车，旗下R1T皮卡于2021年末正式开启交付，还计划于2023年底前在美国和加拿大布局专属充电网络，其平台可适配新车型也可对外授权使用。
ACHC vs RIVN — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $1.3B |
| 净利润 | $-1.2B | $-811.0M |
| 毛利率 | — | 9.3% |
| 营业利润率 | -142.4% | -64.8% |
| 净利率 | -143.3% | -63.1% |
| 营收同比 | 6.1% | -25.8% |
| 净利润同比 | -3710.4% | -9.0% |
| 每股收益（稀释后） | $-12.98 | $-0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $821.5M | $1.3B | ||
| Q3 25 | $851.6M | $1.6B | ||
| Q2 25 | $869.2M | $1.3B | ||
| Q1 25 | $770.5M | $1.2B | ||
| Q4 24 | $774.2M | $1.7B | ||
| Q3 24 | $815.6M | $874.0M | ||
| Q2 24 | $796.0M | $1.2B | ||
| Q1 24 | $768.1M | $1.2B |
| Q4 25 | $-1.2B | $-811.0M | ||
| Q3 25 | $36.2M | $-1.2B | ||
| Q2 25 | $30.1M | $-1.1B | ||
| Q1 25 | $8.4M | $-545.0M | ||
| Q4 24 | $32.6M | $-744.0M | ||
| Q3 24 | $68.1M | $-1.1B | ||
| Q2 24 | $78.5M | $-1.5B | ||
| Q1 24 | $76.4M | $-1.4B |
| Q4 25 | — | 9.3% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | -15.8% | ||
| Q1 25 | — | 16.6% | ||
| Q4 24 | — | 9.8% | ||
| Q3 24 | — | -44.9% | ||
| Q2 24 | — | -38.9% | ||
| Q1 24 | — | -43.8% |
| Q4 25 | -142.4% | -64.8% | ||
| Q3 25 | 4.7% | -63.1% | ||
| Q2 25 | 5.8% | -85.5% | ||
| Q1 25 | 1.7% | -52.8% | ||
| Q4 24 | 4.9% | -38.1% | ||
| Q3 24 | 12.1% | -133.8% | ||
| Q2 24 | 13.4% | -118.7% | ||
| Q1 24 | 12.9% | -123.3% |
| Q4 25 | -143.3% | -63.1% | ||
| Q3 25 | 4.3% | -75.3% | ||
| Q2 25 | 3.5% | -85.7% | ||
| Q1 25 | 1.1% | -44.0% | ||
| Q4 24 | 4.2% | -42.9% | ||
| Q3 24 | 8.4% | -125.9% | ||
| Q2 24 | 9.9% | -125.8% | ||
| Q1 24 | 9.9% | -120.1% |
| Q4 25 | $-12.98 | $-0.66 | ||
| Q3 25 | $0.40 | $-0.96 | ||
| Q2 25 | $0.33 | $-0.97 | ||
| Q1 25 | $0.09 | $-0.48 | ||
| Q4 24 | $0.36 | $-0.67 | ||
| Q3 24 | $0.74 | $-1.08 | ||
| Q2 24 | $0.85 | $-1.46 | ||
| Q1 24 | $0.83 | $-1.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $6.1B |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $1.9B | $4.6B |
| 总资产 | $5.5B | $14.9B |
| 负债/权益比越低杠杆越低 | 1.28× | — |
8季度趋势，按日历期对齐
| Q4 25 | $133.2M | $6.1B | ||
| Q3 25 | $118.7M | $7.1B | ||
| Q2 25 | $131.4M | $7.5B | ||
| Q1 25 | $91.2M | $7.2B | ||
| Q4 24 | $76.3M | $7.7B | ||
| Q3 24 | $82.1M | $6.7B | ||
| Q2 24 | $77.2M | $7.9B | ||
| Q1 24 | $77.3M | $7.9B |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | $5.5B | ||
| Q1 24 | $1.9B | $4.4B |
| Q4 25 | $1.9B | $4.6B | ||
| Q3 25 | $3.1B | $5.1B | ||
| Q2 25 | $3.1B | $6.1B | ||
| Q1 25 | $3.0B | $6.2B | ||
| Q4 24 | $3.1B | $6.6B | ||
| Q3 24 | $3.0B | $5.9B | ||
| Q2 24 | $3.0B | $6.8B | ||
| Q1 24 | $2.9B | $8.1B |
| Q4 25 | $5.5B | $14.9B | ||
| Q3 25 | $6.4B | $15.2B | ||
| Q2 25 | $6.3B | $15.6B | ||
| Q1 25 | $6.1B | $15.5B | ||
| Q4 24 | $6.0B | $15.4B | ||
| Q3 24 | $5.9B | $14.3B | ||
| Q2 24 | $5.7B | $15.4B | ||
| Q1 24 | $5.5B | $15.7B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | 0.81× | ||
| Q1 24 | 0.65× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $-681.0M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $-1.1B |
| 自由现金流率自由现金流/营收 | -21.8% | -89.0% |
| 资本支出强度资本支出/营收 | 11.3% | 36.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $-2.5B |
8季度趋势，按日历期对齐
| Q4 25 | $-86.3M | $-681.0M | ||
| Q3 25 | $73.2M | $26.0M | ||
| Q2 25 | $133.5M | $64.0M | ||
| Q1 25 | $11.5M | $-188.0M | ||
| Q4 24 | $116.7M | $1.2B | ||
| Q3 24 | $163.1M | $-876.0M | ||
| Q2 24 | $171.1M | $-754.0M | ||
| Q1 24 | $-321.3M | $-1.3B |
| Q4 25 | $-179.5M | $-1.1B | ||
| Q3 25 | $-63.0M | $-421.0M | ||
| Q2 25 | $-34.2M | $-398.0M | ||
| Q1 25 | $-163.2M | $-526.0M | ||
| Q4 24 | $-86.8M | $856.0M | ||
| Q3 24 | $-27.1M | $-1.2B | ||
| Q2 24 | $16.9M | $-1.0B | ||
| Q1 24 | $-463.7M | $-1.5B |
| Q4 25 | -21.8% | -89.0% | ||
| Q3 25 | -7.4% | -27.0% | ||
| Q2 25 | -3.9% | -30.5% | ||
| Q1 25 | -21.2% | -42.4% | ||
| Q4 24 | -11.2% | 49.4% | ||
| Q3 24 | -3.3% | -131.9% | ||
| Q2 24 | 2.1% | -89.6% | ||
| Q1 24 | -60.4% | -126.5% |
| Q4 25 | 11.3% | 36.0% | ||
| Q3 25 | 16.0% | 28.7% | ||
| Q2 25 | 19.3% | 35.5% | ||
| Q1 25 | 22.7% | 27.3% | ||
| Q4 24 | 26.3% | 18.9% | ||
| Q3 24 | 23.3% | 31.7% | ||
| Q2 24 | 19.4% | 24.4% | ||
| Q1 24 | 18.5% | 21.1% |
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — | ||
| Q1 24 | -4.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
RIVN
| Automotive Segment | $839.0M | 65% |
| Software And Services Segment | $447.0M | 35% |
| Regulatory Credits | $30.0M | 2% |
